Arrowhead, Novartis Ink Agreement
LA500 2025: Christopher Anzalone
Arrowhead Pharma Shares See Big Price Jump
Arrowhead Teeing Up Drug Trials
LA500 2024: Christopher Anzalone
Arrowhead Drugs Progress
LA500 2023: Christopher Anzalone
Arrowhead Pharmaceuticals Receives $25M Payment
LABJ Stock Index: December 1
Everytable Finds Win in Compton
Wells Fargo Snaps Up Munster Freeman Group
Law Firm Ups Its Home Office Space
OpEd: L.A. Must Improve Its Public Relations
